Orphan designation: amitriptyline Treatment of erythromelalgia, 21/06/2022 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 February 2025 - 14:08

Orphan designation: amitriptyline Treatment of erythromelalgia, 21/06/2022 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2626

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters